Efficacy of Plasma Rich in Growth Factors for Healing Chronic Skin Ulcers: A Systematic Review of Randomized Controlled Trials With Meta-Analysis
Wounds: a compendium of clinical research and practice · 2024 · 36 (6) · 189-200
DOI: 10.25270/wnds/23122 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Wounds: a compendium of clinical research and practice, 2024. Verfasst von Eduardo Anitua und 2 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Chronic skin ulceration is a serious pathological condition for which the adjuvant use of platelet-rich plasma (PRP) has been indicated. However, evidence for the use of PRP in patients with chronic skin ulcers remains insufficient due to a large heterogeneity in experimental designs, PRP composition, and preparation protocols.
Objective
To assess previously published reports of the clinical effect of plasma rich in growth factors (PRGF) on chronic skin wounds.
Methods
A comprehensive search of the PubMed, Cochrane Library, and Scopus databases was performed to identify randomized controlled trials (RCTs) assessing the effect of PRGF on chronic ulcer healing, with no limitation regarding publication date (up to September 1, 2022). Percentage area reduction and probability of complete healing in chronic ulcers, pain reduction, infection risk, and cost savings were analyzed. A meta-analysis was performed, and the overall evidence was qualified using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) approach.
Results
A total of 113 studies were identified. After full-text screening, 5 RCTs met the inclusion criteria. The meta-analysis showed a significant effect of PRGF on both wound area reduction (mean difference, 56.90% [95% CI, 52.28-61.51], I² = 0%; P = .56) and on the probability of complete healing (RR, 7.07 [95% CI, 1.84-27.16], I² = 0%; P = .53) in chronic ulcers. The overall risk of bias rating was “some concerns,” whereas the certainty of evidence was high for both outcomes. A qualitative analysis suggested that PRGF did not increase infection risk and was able to reduce wound pain.
Conclusion
The use of PRGF significantly enhances wound area reduction and also the probability of complete healing in chronic ulcers. More studies are needed to assess the effect of PRGF on pain and infection, as well as its cost-effectiveness.
Zitieren
APA
Anitua, E., Pino, A., & Alkhraisat, M. (2024). Efficacy of Plasma Rich in Growth Factors for Healing Chronic Skin Ulcers: A Systematic Review of Randomized Controlled Trials With Meta-Analysis. Wounds: a compendium of clinical research and practice, 36(6), 189-200. https://doi.org/10.25270/wnds/23122
Vancouver
Anitua E, Pino A, Alkhraisat M. Efficacy of Plasma Rich in Growth Factors for Healing Chronic Skin Ulcers: A Systematic Review of Randomized Controlled Trials With Meta-Analysis. Wounds: a compendium of clinical research and practice. 2024;36(6):189-200. doi:10.25270/wnds/23122
BibTeX
@article{Anitua2024,
author = {Anitua, Eduardo and Pino, Ander and Alkhraisat, Mohammad},
title = {Efficacy of Plasma Rich in Growth Factors for Healing Chronic Skin Ulcers: A Systematic Review of Randomized Controlled Trials With Meta-Analysis},
journal = {Wounds: a compendium of clinical research and practice},
year = {2024},
volume = {36},
number = {6},
pages = {189--200},
doi = {10.25270/wnds/23122}
}
EUVIMED